Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Alfonso Urbanucci
Based on 17 articles published since 2009
(Why 17 articles?)
||||
Expertise Level
The expertise of Alfonso Urbanucci ranks in the
  • Top 1.1%
  • ... of 132,850 published authors worldwide on Prostatic Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 17 articles on the topic.
Graphical view (beta)
Aliases Urbanucci, A   ·   Urbanucci, Alfonso
Work Locations
Details
Most likely:    University of Oslo      
2018
  • Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, University of Oslo, Forskningsparken, Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Electronic address: · Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, University of Oslo, Forskningsparken, Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Prostate Cancer UK/Movember Centre of Excellence for Prostate Cancer, Centre for Cancer Research and Cell Biology, Queen's University of Belfast, BT9 7AE Belfast, UK. · Pubmed 28624514
  • Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Finsen Laboratory, Rigshospitalet, DK-2200, Copenhagen, Denmark; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, DK-2200, Copenhagen, Denmark. · Max Planck Institute for Molecular Genetics, Otto Warburg Laboratory Gene Regulation and Systems Biology of Cancer, Ihnestrasse 63-73, 14195 Berlin, Germany. · Department of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. · Division Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. · Division of Cancer Genome Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany. · European Molecular Biology Laboratory (EMBL), Genome Biology Unit, 69120 Heidelberg, Germany. · Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Department for Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg, Heidelberg 69120, Germany; Department of Pediatric Immunology, Hematology and Oncology, University Hospital, Heidelberg 69120, Germany. · Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forskningsparken, University of Oslo, 0316 Oslo, Norway; Institute for Cancer Genetics and Informatics, Oslo University Hospital, 0316 Oslo, Norway; Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, 0316 Oslo, Norway. · Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences, Durham, 27709 NC, USA. · Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, Durham, 27709 NC, USA. · Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany. · PROGETHER Prostate Cancer Network, 0316 Oslo, Norway. · Martini-Clinic Prostate Cancer Center at the University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. · Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Department of Urology, UT Southwestern Medical Center, Dallas, TX 75390-9110, USA. · Informatics & Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Canada. · Division of Cancer Genome Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; NCT Trial Center, National Center for Tumor Diseases and German Cancer Research Center, 69120 Heidelberg, Germany. · Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Department for Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg, Heidelberg 69120, Germany. · Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Bioinformatics and Omics Data Analytics (B240), German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. · Manchester Cancer Research Centre, University of Manchester, 555 Wilmslow Road, Manchester, UK. · Ontario Institute for Cancer Research, Toronto, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Canada. · German Cancer Consortium (DKTK), 69120 Heidelberg, Germany; Division of Translational Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Division Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany. · Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany. · European Molecular Biology Laboratory (EMBL), Genome Biology Unit, 69120 Heidelberg, Germany. Electronic address: · Martini-Clinic Prostate Cancer Center at the University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany; Charité Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Finsen Laboratory, Rigshospitalet, DK-2200, Copenhagen, Denmark; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, DK-2200, Copenhagen, Denmark; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, 69120 Heidelberg, Germany; Charité Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Pubmed 30537516
2017
  • BioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · BioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forksningsparken, University of Oslo, Oslo, Norway. · Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · K.G. Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway. · Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21287, USA. · Pubmed 29269934
  • Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forskningsparken, University of Oslo, 21 0349 Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, 0424 Oslo, Norway. Electronic address: · Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forskningsparken, University of Oslo, 21 0349 Oslo, Norway. · Prostate Cancer Research Center, Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere and Tampere University of Technology, 33520 Tampere, Finland. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. · Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, 0424 Oslo, Norway. · Prostate Cancer Research Center, Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere and Fimlab Laboratories, Tampere University Hospital, 33520 Tampere, Finland. · Department of Biosciences, University of Oslo, 0316 Oslo, Norway. · Department of Pathology, Fimlab Laboratories, Tampere University Hospital, 33520 Tampere, Finland. · University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany. · General, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. · Department of Surgery - Section of Urology, University of Chicago, Chicago, IL 60637, USA; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109-0940, USA. · Research and Development, GenomeDx Biosciences, Vancouver, BC V6B 1B8, Canada. · Department of Medicine, University of California at San Francisco, San Francisco, CA 94143-0410, USA; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA 94143-0981, USA. · Department of Urology, Mayo Clinic, Rochester, MN 55902, USA. · Brady Urological Institute, Johns Hopkins Medical Institute, Baltimore, MD 21287, USA. · Department of Urology, Northwestern University, Feinberg School of Medicine, 303 East Chicago Avenue, Tarry 16-703, Chicago, IL 60611-3008, USA. · Department of Surgery - Section of Urology, University of Chicago, Chicago, IL 60637, USA. · Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus, Roosevelt Drive, Oxford OX3 7DQ, UK; Institute for Pharmaceutical Chemistry, Goethe-University Frankfurt, Campus Riedberg, Max-von Laue Strasse 9, 60438 Frankfurt am Main, Germany. · Department of Urology, University of Washington, Seattle, WA 98195, USA. · Department of Medicine, University of California at San Francisco, San Francisco, CA 94143-0410, USA; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA 94143-0981, USA; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA 94115, USA. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Department of Urology, University of Washington, Seattle, WA 98195, USA; Department of Pathology, University of Washington, Seattle, WA 98195, USA. · Department of Biosciences, University of Oslo, 0316 Oslo, Norway; Institute for Cancer Genetics and Informatics, Oslo University Hospital, 0424 Oslo, Norway. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA. · Prostate Cancer Research Center and Department of Urology, University of Tampere and Tampere University Hospital, 33014 Tampere, Finland. · Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg 20095, Germany. · Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forskningsparken, University of Oslo, 21 0349 Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, 0424 Oslo, Norway; PCUK Movember Centre of Excellence, CCRCB, Queen's University, Belfast BT7 1NN, Northern Ireland, UK. Electronic address: · Pubmed 28591577
  • Prostate Cancer Research Group, Centre for Molecular Medicine Norway, University of Oslo, Oslo, Norway. · Genito Urinary Cancer Research Group, Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom. · Department of Molecular Oncology, Institute for Cancer Research and Oslo University Hospital, Oslo, Norway. · Department of Surgery and Cancer, Imperial College London, London, United Kingdom. · GenomeDx Biosciences, Vancouver, British Columbia, Canada. · Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio, USA. · Department of Hematology/Medical Oncology, Cleveland Clinic, Cleveland, Ohio, USA. · Department of Oncology, Laboratory of Lipid Metabolism and Cancer, LKI Leuven Cancer Institute, KU Leuven-University of Leuven, Leuven, Belgium. · Department of Cellular and Molecular Medicine, Laboratory of Protein Phosphorylation and Proteomics, KU Leuven-University of Leuven, Leuven, Belgium. · Department of Urology, Roswell Park Cancer Institute, Buffalo, New York, USA. · PCUK/Movember Centre of Excellence for Prostate Cancer Research, CRUK Manchester Institute for Cancer Research, University of Manchester, Manchester, UK. · Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. · Department of Medical Biology, University of Tromso, Tromso Norway. · PCUK/Movember Centre of Excellence for Prostate Cancer Research, Centre for Cancer Research and Cell Biology (CCRCB), Queen's University Belfast, Belfast, UK. · Pubmed 28415728
  • Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo, Oslo, Norway. Electronic address: · Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo, Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Electronic address: · Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo, Oslo, Norway. · The Vancouver Prostate Centre, University of British Columbia, Canada. · Department of Biosciences, University of Oslo, Oslo, Norway. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA. · Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo, Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; PCUK/Movember Centre of Excellence, CCRCB, Queen's University, Belfast, UK. Electronic address: · Pubmed 28412251
  • Prostate Cancer Research Group, Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, Faculty of Medicine, University of Oslo, Oslo, Norway. · NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. · Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK. · Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · PCUK Movember Centre of Excellence, CCRCB, Queen's University, Belfast, UK. · Prostate Cancer Research Group, Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · Pubmed 28359301
2015
  • Prostate Cancer Research Center (PCRC), Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere and Tampere University Hospital, Tampere, Finland. · Adult Cancer Program, The Prince of Wales Clinical School, Lowy Cancer Research Centre, UNSW Medicine, University of New South Wales, Sydney, Australia. · YCR Cancer Research Unit, Department of Biology, The University of York, Heslington, United Kingdom. · Department of Signal Processing, Tampere University of Technology, Tampere, Finland. · Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway. · Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland. · Department of Pathology, University of Turku, Turku, Finland. · Pubmed 25965834
  • Prostate Research Group, Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo, Oslo, Norway. · The Vancouver Prostate Centre, University of British Columbia, British Columbia, Canada. · Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Malmö, Sweden. · Department of Medical Biochemistry and Biophysics, Molecular Infection Medicine Sweden (MIMS), Nordic EMBL Partnership, University of Umeå, Umeå, Sweden. · Institute of Biosciences and Medical Technology, University of Tampere and Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Department of Cancer Prevention, Oslo University Hospital, Oslo, Norway. · Department of Urology, Oslo University Hospital, Oslo, Norway. · Pubmed 25869206
2014
  • Prostate Cancer Research GroupCentre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, NorwayDepartment of Cancer PreventionInstitute of Cancer ResearchDepartment of UrologyOslo University Hospital, N-0424 Oslo, Norway. · Prostate Cancer Research GroupCentre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, NorwayDepartment of Cancer PreventionInstitute of Cancer ResearchDepartment of UrologyOslo University Hospital, N-0424 Oslo, NorwayProstate Cancer Research GroupCentre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, NorwayDepartment of Cancer PreventionInstitute of Cancer ResearchDepartment of UrologyOslo University Hospital, N-0424 Oslo, NorwayProstate Cancer Research GroupCentre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, NorwayDepartment of Cancer PreventionInstitute of Cancer ResearchDepartment of UrologyOslo University Hospital, N-0424 Oslo, Norway · Pubmed 24497572
Probable:    University of Tampere      
2017
  • BioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · BioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forksningsparken, University of Oslo, Oslo, Norway. · Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · K.G. Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway. · Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21287, USA. · Pubmed 29269934
2015
  • Prostate Cancer Research Center (PCRC), Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere and Tampere University Hospital, Tampere, Finland. · Adult Cancer Program, The Prince of Wales Clinical School, Lowy Cancer Research Centre, UNSW Medicine, University of New South Wales, Sydney, Australia. · YCR Cancer Research Unit, Department of Biology, The University of York, Heslington, United Kingdom. · Department of Signal Processing, Tampere University of Technology, Tampere, Finland. · Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway. · Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland. · Department of Pathology, University of Turku, Turku, Finland. · Pubmed 25965834
2012
  • Institute of Biomedical Technology and BioMediTech, University of Tampere and Tampere University Hospital, Tampere, Finland. · Pubmed 22212979
  • Institute of Biomedical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland. · Pubmed 21909140
2013
  • Institute of Biomedical Technology and BioMediTech, University of Tampere and Tampere University Hospital, Tampere, Finland. · Pubmed 22674191
2012
  • Computational Systems Biology, Tampere University of Technology, Tampere, Finland. · Pubmed 22245783
  • Institute of Biomedical Technology and BioMediTech, University of Tampere and Tampere University Hospital, Finland. · Pubmed 22431170
  • Institute of Biomedical Technology, Tampere University, Tampere, Finland. · Pubmed 22266859
2011
  • Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland. · Pubmed 20945501
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 17 total) written by Alfonso Urbanucci about Prostatic Neoplasms:

  • Bromodomain-containing proteins in prostate cancer. 2018
  • Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories. 2018
  • The expression of AURKA is androgen regulated in castration-resistant prostate cancer. 2017
  • Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer. 2017
  • Lipid degradation promotes prostate cancer cell survival. 2017
  • c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks. 2017
  • Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer. 2017
  • CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations. 2015
  • Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer. 2015
  • Androgen-regulated metabolism and biosynthesis in prostate cancer. 2014
Show List of Full Article Records
Google Searches

Learn more about Alfonso Urbanucci using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Oslo
University of Tampere
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Oslo
2018
  • Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, University of Oslo, Forskningsparken, Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Electronic address: · Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, University of Oslo, Forskningsparken, Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Prostate Cancer UK/Movember Centre of Excellence for Prostate Cancer, Centre for Cancer Research and Cell Biology, Queen's University of Belfast, BT9 7AE Belfast, UK. · Pubmed 28624514
  • Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Finsen Laboratory, Rigshospitalet, DK-2200, Copenhagen, Denmark; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, DK-2200, Copenhagen, Denmark. · Max Planck Institute for Molecular Genetics, Otto Warburg Laboratory Gene Regulation and Systems Biology of Cancer, Ihnestrasse 63-73, 14195 Berlin, Germany. · Department of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. · Division Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. · Division of Cancer Genome Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany. · European Molecular Biology Laboratory (EMBL), Genome Biology Unit, 69120 Heidelberg, Germany. · Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Department for Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg, Heidelberg 69120, Germany; Department of Pediatric Immunology, Hematology and Oncology, University Hospital, Heidelberg 69120, Germany. · Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forskningsparken, University of Oslo, 0316 Oslo, Norway; Institute for Cancer Genetics and Informatics, Oslo University Hospital, 0316 Oslo, Norway; Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, 0316 Oslo, Norway. · Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences, Durham, 27709 NC, USA. · Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, Durham, 27709 NC, USA. · Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany. · PROGETHER Prostate Cancer Network, 0316 Oslo, Norway. · Martini-Clinic Prostate Cancer Center at the University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. · Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Department of Urology, UT Southwestern Medical Center, Dallas, TX 75390-9110, USA. · Informatics & Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Canada. · Division of Cancer Genome Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; NCT Trial Center, National Center for Tumor Diseases and German Cancer Research Center, 69120 Heidelberg, Germany. · Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Department for Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg, Heidelberg 69120, Germany. · Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Bioinformatics and Omics Data Analytics (B240), German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. · Manchester Cancer Research Centre, University of Manchester, 555 Wilmslow Road, Manchester, UK. · Ontario Institute for Cancer Research, Toronto, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Canada. · German Cancer Consortium (DKTK), 69120 Heidelberg, Germany; Division of Translational Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Division Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany. · Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany. · European Molecular Biology Laboratory (EMBL), Genome Biology Unit, 69120 Heidelberg, Germany. Electronic address: · Martini-Clinic Prostate Cancer Center at the University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany; Charité Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Finsen Laboratory, Rigshospitalet, DK-2200, Copenhagen, Denmark; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, DK-2200, Copenhagen, Denmark; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, 69120 Heidelberg, Germany; Charité Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Pubmed 30537516
2017
  • BioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · BioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forksningsparken, University of Oslo, Oslo, Norway. · Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · K.G. Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway. · Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21287, USA. · Pubmed 29269934
  • Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forskningsparken, University of Oslo, 21 0349 Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, 0424 Oslo, Norway. Electronic address: · Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forskningsparken, University of Oslo, 21 0349 Oslo, Norway. · Prostate Cancer Research Center, Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere and Tampere University of Technology, 33520 Tampere, Finland. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. · Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, 0424 Oslo, Norway. · Prostate Cancer Research Center, Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere and Fimlab Laboratories, Tampere University Hospital, 33520 Tampere, Finland. · Department of Biosciences, University of Oslo, 0316 Oslo, Norway. · Department of Pathology, Fimlab Laboratories, Tampere University Hospital, 33520 Tampere, Finland. · University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany. · General, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. · Department of Surgery - Section of Urology, University of Chicago, Chicago, IL 60637, USA; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109-0940, USA. · Research and Development, GenomeDx Biosciences, Vancouver, BC V6B 1B8, Canada. · Department of Medicine, University of California at San Francisco, San Francisco, CA 94143-0410, USA; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA 94143-0981, USA. · Department of Urology, Mayo Clinic, Rochester, MN 55902, USA. · Brady Urological Institute, Johns Hopkins Medical Institute, Baltimore, MD 21287, USA. · Department of Urology, Northwestern University, Feinberg School of Medicine, 303 East Chicago Avenue, Tarry 16-703, Chicago, IL 60611-3008, USA. · Department of Surgery - Section of Urology, University of Chicago, Chicago, IL 60637, USA. · Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus, Roosevelt Drive, Oxford OX3 7DQ, UK; Institute for Pharmaceutical Chemistry, Goethe-University Frankfurt, Campus Riedberg, Max-von Laue Strasse 9, 60438 Frankfurt am Main, Germany. · Department of Urology, University of Washington, Seattle, WA 98195, USA. · Department of Medicine, University of California at San Francisco, San Francisco, CA 94143-0410, USA; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA 94143-0981, USA; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA 94115, USA. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Department of Urology, University of Washington, Seattle, WA 98195, USA; Department of Pathology, University of Washington, Seattle, WA 98195, USA. · Department of Biosciences, University of Oslo, 0316 Oslo, Norway; Institute for Cancer Genetics and Informatics, Oslo University Hospital, 0424 Oslo, Norway. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA. · Prostate Cancer Research Center and Department of Urology, University of Tampere and Tampere University Hospital, 33014 Tampere, Finland. · Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg 20095, Germany. · Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forskningsparken, University of Oslo, 21 0349 Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, 0424 Oslo, Norway; PCUK Movember Centre of Excellence, CCRCB, Queen's University, Belfast BT7 1NN, Northern Ireland, UK. Electronic address: · Pubmed 28591577
  • Prostate Cancer Research Group, Centre for Molecular Medicine Norway, University of Oslo, Oslo, Norway. · Genito Urinary Cancer Research Group, Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom. · Department of Molecular Oncology, Institute for Cancer Research and Oslo University Hospital, Oslo, Norway. · Department of Surgery and Cancer, Imperial College London, London, United Kingdom. · GenomeDx Biosciences, Vancouver, British Columbia, Canada. · Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio, USA. · Department of Hematology/Medical Oncology, Cleveland Clinic, Cleveland, Ohio, USA. · Department of Oncology, Laboratory of Lipid Metabolism and Cancer, LKI Leuven Cancer Institute, KU Leuven-University of Leuven, Leuven, Belgium. · Department of Cellular and Molecular Medicine, Laboratory of Protein Phosphorylation and Proteomics, KU Leuven-University of Leuven, Leuven, Belgium. · Department of Urology, Roswell Park Cancer Institute, Buffalo, New York, USA. · PCUK/Movember Centre of Excellence for Prostate Cancer Research, CRUK Manchester Institute for Cancer Research, University of Manchester, Manchester, UK. · Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. · Department of Medical Biology, University of Tromso, Tromso Norway. · PCUK/Movember Centre of Excellence for Prostate Cancer Research, Centre for Cancer Research and Cell Biology (CCRCB), Queen's University Belfast, Belfast, UK. · Pubmed 28415728
  • Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo, Oslo, Norway. Electronic address: · Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo, Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Electronic address: · Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo, Oslo, Norway. · The Vancouver Prostate Centre, University of British Columbia, Canada. · Department of Biosciences, University of Oslo, Oslo, Norway. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA. · Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo, Oslo, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; PCUK/Movember Centre of Excellence, CCRCB, Queen's University, Belfast, UK. Electronic address: · Pubmed 28412251
  • Prostate Cancer Research Group, Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, Faculty of Medicine, University of Oslo, Oslo, Norway. · NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. · Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK. · Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · PCUK Movember Centre of Excellence, CCRCB, Queen's University, Belfast, UK. · Prostate Cancer Research Group, Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · Pubmed 28359301
2015
  • Prostate Cancer Research Center (PCRC), Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere and Tampere University Hospital, Tampere, Finland. · Adult Cancer Program, The Prince of Wales Clinical School, Lowy Cancer Research Centre, UNSW Medicine, University of New South Wales, Sydney, Australia. · YCR Cancer Research Unit, Department of Biology, The University of York, Heslington, United Kingdom. · Department of Signal Processing, Tampere University of Technology, Tampere, Finland. · Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway. · Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland. · Department of Pathology, University of Turku, Turku, Finland. · Pubmed 25965834
  • Prostate Research Group, Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo, Oslo, Norway. · The Vancouver Prostate Centre, University of British Columbia, British Columbia, Canada. · Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Malmö, Sweden. · Department of Medical Biochemistry and Biophysics, Molecular Infection Medicine Sweden (MIMS), Nordic EMBL Partnership, University of Umeå, Umeå, Sweden. · Institute of Biosciences and Medical Technology, University of Tampere and Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Department of Cancer Prevention, Oslo University Hospital, Oslo, Norway. · Department of Urology, Oslo University Hospital, Oslo, Norway. · Pubmed 25869206
2014
  • Prostate Cancer Research GroupCentre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, NorwayDepartment of Cancer PreventionInstitute of Cancer ResearchDepartment of UrologyOslo University Hospital, N-0424 Oslo, Norway. · Prostate Cancer Research GroupCentre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, NorwayDepartment of Cancer PreventionInstitute of Cancer ResearchDepartment of UrologyOslo University Hospital, N-0424 Oslo, NorwayProstate Cancer Research GroupCentre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, NorwayDepartment of Cancer PreventionInstitute of Cancer ResearchDepartment of UrologyOslo University Hospital, N-0424 Oslo, NorwayProstate Cancer Research GroupCentre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, NorwayDepartment of Cancer PreventionInstitute of Cancer ResearchDepartment of UrologyOslo University Hospital, N-0424 Oslo, Norway · Pubmed 24497572
University of Tampere
2017
  • BioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · BioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forksningsparken, University of Oslo, Oslo, Norway. · Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · K.G. Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway. · Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21287, USA. · Pubmed 29269934
2015
  • Prostate Cancer Research Center (PCRC), Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere and Tampere University Hospital, Tampere, Finland. · Adult Cancer Program, The Prince of Wales Clinical School, Lowy Cancer Research Centre, UNSW Medicine, University of New South Wales, Sydney, Australia. · YCR Cancer Research Unit, Department of Biology, The University of York, Heslington, United Kingdom. · Department of Signal Processing, Tampere University of Technology, Tampere, Finland. · Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway. · Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland. · Department of Pathology, University of Turku, Turku, Finland. · Pubmed 25965834
2012
  • Institute of Biomedical Technology and BioMediTech, University of Tampere and Tampere University Hospital, Tampere, Finland. · Pubmed 22212979
  • Institute of Biomedical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland. · Pubmed 21909140
2013
  • Institute of Biomedical Technology and BioMediTech, University of Tampere and Tampere University Hospital, Tampere, Finland. · Pubmed 22674191
2012
  • Computational Systems Biology, Tampere University of Technology, Tampere, Finland. · Pubmed 22245783
  • Institute of Biomedical Technology and BioMediTech, University of Tampere and Tampere University Hospital, Finland. · Pubmed 22431170
  • Institute of Biomedical Technology, Tampere University, Tampere, Finland. · Pubmed 22266859
2011
  • Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland. · Pubmed 20945501
Yearly article counts 02502115100
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.